Brussels, 20 April 2023 - EuropaBio is delighted to announce that 21st.BIO has joined as an Associate SME member.

Founded in 2020, 21st.BIO is a technology and service partner for companies in the precision fermentation space. The company builds state-of-the-art production strains and fermentation processes and help their customers transition fast and efficiently from molecule innovation to cost effective large-scale production. 21st.BIO has among other a global license to a selected part of Novozymes expression technology platform . The focus areas of 21st.BIO include proteins and peptides for the food, materials and agricultural industries.

EuropaBio Director-General Dr. Claire Skentelbery commented “Europe continues to show its strength from industrial biotechnology with young companies such as 21st.BIO leading the competitiveness race. We are delighted to welcome them to EuropaBio and look forward to showcasing their technologies and business growth”.

Thomas Schmidt, 21st.BIO CEO added “As the world continues to focus on sustainability and better and cleaner nutrition and materials, bio-based solutions are becoming increasingly important. Yet, way too few promising innovations and new molecules have been successfully commercialized and made a true impact to the world.”